Delivery Order SPE2DB22D1103-SPE2DB24FTRK5

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AMBIEN CR 6.25 MG TABLET 100S. The contract has a total ceiling value of $3,039.12 and a period of performance through July 26, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
This is a $3,323.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ambien CR 6.25 mg tablets. It has a completion date of June 6, 2025 and is not set aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ambien CR 12.5 mg tablets. The contract has a fixed price of $2,286.86 and a completion date of August 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which allows the agency to efficiently...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ambien CR 6.25 mg tablets, with a ceiling value of $3,635.50 and a period of performance through May 19, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMBIEN CR 6.25 mg tablets, with a ceiling value of $5,595.56 and a period of performance through June 26, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,332.82, is for the delivery of Ambien CR 6.25 mg tablets in quantities of 100 per bottle. The contract has an ultimate completion date of May 30, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AMBIEN CR 12.5 MG TABLET 100S, a prescription sleep medication, with a ceiling value of $2,267.44 and a performance period ending on August 16, 2024. The contract is a firm-fixed-price, non-set-aside vehicle. AmerisourceBergen, through its extensive federal contracting experience and logistics...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ambien CR 6.25 mg tablets. The contract has a ceiling value of $11,517.50 and a period of performance ending on July 8, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and this award is associated with a larger Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,477.66, is for the supply of 4,568,175,921 units of Ambien CR 12.5 mg tablets. The contract has a period of performance through May 8, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ambien CR 12.5 mg tablets. The contract is a Delivery Order with a Firm Fixed Price of $4,558.68 and an ultimate completion date of August 14, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTRK5
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Ambien CR 6.25 mg tablets. The contract has a ceiling value of $2,767.19 and an ultimate completion date of September 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities, including prescription drugs and medical supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/13/24, 9:23 AM